USD 23.3
(0.23%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | -136.88 Million USD | 22.29% |
2023 | -176.14 Million USD | -49.07% |
2022 | -118.16 Million USD | -332.95% |
2021 | -27.29 Million USD | -34.49% |
2020 | -20.29 Million USD | -34.73% |
2019 | -15.06 Million USD | 17.21% |
2018 | -18.19 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q4 | -30.64 Million USD | 4.05% |
2024 FY | -136.88 Million USD | 22.29% |
2024 Q3 | -31.94 Million USD | 13.13% |
2024 Q1 | -37.53 Million USD | 1.29% |
2024 Q2 | -36.76 Million USD | 2.04% |
2023 Q3 | -40.16 Million USD | 14.02% |
2023 Q2 | -46.71 Million USD | 8.83% |
2023 FY | -176.14 Million USD | -49.07% |
2023 Q1 | -51.24 Million USD | -10.31% |
2023 Q4 | -38.02 Million USD | 5.34% |
2022 Q2 | -24.39 Million USD | -122.28% |
2022 Q1 | -10.97 Million USD | -35.55% |
2022 Q3 | -36.34 Million USD | -48.99% |
2022 FY | -118.16 Million USD | -332.95% |
2022 Q4 | -46.45 Million USD | -27.81% |
2021 Q2 | -6.37 Million USD | -4.24% |
2021 Q1 | -6.11 Million USD | -66.63% |
2021 Q3 | -6.71 Million USD | -5.37% |
2021 Q4 | -8.09 Million USD | -20.6% |
2021 FY | -27.29 Million USD | -34.49% |
2020 FY | -20.29 Million USD | -34.73% |
2020 Q3 | -2.43 Million USD | 67.48% |
2020 Q4 | -3.66 Million USD | -50.51% |
2020 Q2 | -7.49 Million USD | -11.93% |
2020 Q1 | -6.69 Million USD | -31.81% |
2019 FY | -15.06 Million USD | 17.21% |
2019 Q4 | -5.07 Million USD | -21.74% |
2019 Q1 | -3.22 Million USD | 0.0% |
2019 Q2 | -2.58 Million USD | 19.75% |
2019 Q3 | -4.17 Million USD | -61.27% |
2018 FY | -18.19 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
American Well Corporation | -675.16 Million USD | 79.726% |
Doximity, Inc. | 147.58 Million USD | 192.752% |
Evolent Health, Inc. | -113.04 Million USD | -21.094% |
MultiPlan Corporation | -91.69 Million USD | -49.28% |
Teladoc Health, Inc. | -220.36 Million USD | 37.883% |
Veeva Systems Inc. | 525.7 Million USD | 126.038% |